Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00986882 | To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients | PHASE2 | COMPLETED | 183 | — | — | Sep 1, 2009 | Mar 1, 2011 | Dec 19, 2020 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| SAF312A (2 doses in part B; 5 - 6 doses in part C) | EXPERIMENTAL | - |
| Placebo | PLACEBO_COMPARATOR | - |
| Ibuprofen | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| SAF312A | DRUG | - |
| Placebo | DRUG | - |
| Ibuprofen | DRUG | - |
Inclusion Criteria: * Extraction of two or more impacted (partial or full) third molars. At least one of the impaction should be lower jaw. * Each patient will evaluate her/his post-surgical pain intensity prior to taking trial medication. * To be eligible for this trial, post surgical pain must be...